Activation of the extracellular signal-regulated kinase by complement C5b-9

被引:33
作者
Cybulsky, AV
Takano, T
Papillon, J
Bijian, K
Guillemette, J
机构
[1] Royal Victoria Hosp, Div Nephrol, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ, Canada
关键词
glomerular epithelial cell; inflammation; protein kinases; signal transduction;
D O I
10.1152/ajprenal.00066.2005
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Extracellular signals may be transmitted to nuclear or cytoplasmic effectors via the mitogen-activated protein kinases. In the passive Heymann nephritis (PHN) model of membranous nephropathy, complement C5b-9 induces glomerular epithelial cell (GEC) injury, proteinuria, and activation of phospholipases and protein kinases. This study addresses the complement-mediated activation of the extracellular signal-regulated kinase (ERK). C5b-9 induced ERK threonine(202)/tyrosine(204) phosphorylation ( which correlates with activation) in GEC in culture and PHN in vivo. Expression of a dominant-inhibitory mutant of Ras reduced complement-mediated activation of ERK, but activation was not affected significantly by downregulation of protein kinase C. Complement-induced ERK activation resulted in phosphorylation of cytosolic phospholipase A(2) and was, in part, responsible for phosphorylation of mitogen-activated protein kinase-associated protein kinase-2, but did not induce phosphorylation of the transcription factor, Elk-1. Activation of ERK was attenuated by drugs that disassemble the actin cytoskeleton ( cytochalasin D, latrunculin B), and these compounds interfered with the activation of ERK by mitogen-activated protein kinase kinase (MEK). Overexpression of a constitutively active RhoA as well as inhibition of Rho-associated kinase blocked complement-mediated ERK activation. Complement cytotoxicity was enhanced after disassembly of the actin cytoskeleton but was unaffected after inhibition of complement-induced ERK activation. However, complement cytotoxicity was enhanced in GEC that stably express constitutively active MEK. Thus complement-induced ERK activation depends on cytoskeletal remodelling and affects the regulation of distinct downstream substrates, while chronic, constitutive ERK activation exacerbates complement-mediated GEC injury.
引用
收藏
页码:F593 / F603
页数:11
相关论文
共 53 条
[21]   Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis [J].
Kraus, S ;
Seger, R ;
Fishelson, Z .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03) :366-374
[22]   Properties and regulation of cytosolic phospholipase A(2) [J].
Leslie, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :16709-16712
[23]   Requirement of cortical actin organization for bombesin, endothelin, and EGF receptor internalization [J].
Lunn, JA ;
Wong, H ;
Rozengurt, E ;
Walsh, JH .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (06) :C2019-C2027
[24]   THE REGULATION OF TYROSINE KINASE SIGNALING PATHWAYS BY GROWTH-FACTOR AND G-PROTEIN-COUPLED RECEPTORS [J].
MALARKEY, K ;
BELHAM, CM ;
PAUL, A ;
GRAHAM, A ;
MCLEES, A ;
SCOTT, PH ;
PLEVIN, R .
BIOCHEMICAL JOURNAL, 1995, 309 :361-375
[25]   TRANSFORMATION OF MAMMALIAN-CELLS BY CONSTITUTIVELY ACTIVE MAP KINASE KINASE [J].
MANSOUR, SJ ;
MATTEN, WT ;
HERMANN, AS ;
CANDIA, JM ;
RONG, S ;
FUKASAWA, K ;
VANDEWOUDE, GF ;
AHN, NG .
SCIENCE, 1994, 265 (5174) :966-970
[26]   SPECIFICITY OF RECEPTOR TYROSINE KINASE SIGNALING - TRANSIENT VERSUS SUSTAINED EXTRACELLULAR SIGNAL-REGULATED KINASE ACTIVATION [J].
MARSHALL, CJ .
CELL, 1995, 80 (02) :179-185
[27]   Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export [J].
Meng, WY ;
Swenson, LL ;
Fitzgibbon, MJ ;
Hayakawa, K ;
ter Haar, E ;
Behrens, AE ;
Fulghum, JR ;
Lippke, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) :37401-37405
[28]  
MORGAN BP, 1992, CURR TOP MICROBIOL, V178, P115
[29]   MEMBRANE SIGNALING BY COMPLEMENT C5B-9, THE MEMBRANE ATTACK COMPLEX [J].
NICHOLSONWELLER, A ;
HALPERIN, JA .
IMMUNOLOGIC RESEARCH, 1993, 12 (03) :244-257
[30]  
Panesar M, 1997, J IMMUNOL, V159, P3584